[{"address1": "6200 Lookout Road", "city": "Boulder", "state": "CO", "zip": "80301", "country": "United States", "phone": "720 647 8519", "website": "https://www.enliventherapeutics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Mr. Samuel S. Kintz M.B.A.", "age": 37, "title": "Co-Founder, CEO, Secretary & Director", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 866409, "exercisedValue": 0, "unexercisedValue": 6852044}, {"maxAge": 1, "name": "Dr. Joseph P. Lyssikatos Ph.D.", "age": 58, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 632673, "exercisedValue": 0, "unexercisedValue": 4161155}, {"maxAge": 1, "name": "Dr. Helen Louise Collins M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 686192, "exercisedValue": 0, "unexercisedValue": 2038291}, {"maxAge": 1, "name": "Mr. Anish  Patel Pharm.D.", "age": 42, "title": "Co-Founder & COO", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Hohl", "age": 33, "title": "CFO & Head of Corporate Development", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 488500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Galya D. Blachman Esq., Ph.D.", "age": 46, "title": "Chief Legal Officer & Head of Business Development", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 21.74, "open": 21.76, "dayLow": 21.5, "dayHigh": 22.217, "regularMarketPreviousClose": 21.74, "regularMarketOpen": 21.76, "regularMarketDayLow": 21.5, "regularMarketDayHigh": 22.217, "forwardPE": -9.01646, "volume": 199834, "regularMarketVolume": 199834, "averageVolume": 255364, "averageVolume10days": 134070, "averageDailyVolume10Day": 134070, "bid": 21.83, "ask": 21.97, "bidSize": 200, "askSize": 200, "marketCap": 1058533440, "fiftyTwoWeekLow": 9.8, "fiftyTwoWeekHigh": 27.673, "fiftyDayAverage": 23.1354, "twoHundredDayAverage": 18.436325, "currency": "USD", "enterpriseValue": 714715904, "floatShares": 24851495, "sharesOutstanding": 47237200, "sharesShort": 5320217, "sharesShortPriorMonth": 5245830, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1126, "heldPercentInsiders": 0.06734, "heldPercentInstitutions": 1.02015, "shortRatio": 23.29, "shortPercentOfFloat": 0.2787, "bookValue": 6.464, "priceToBook": 3.3895419, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -82827000, "trailingEps": -1.91, "forwardEps": -2.43, "enterpriseToEbitda": -7.449, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ELVN", "underlyingSymbol": "ELVN", "shortName": "Enliven Therapeutics, Inc.", "longName": "Enliven Therapeutics, Inc.", "firstTradeDateEpochUtc": 1584019800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "467fab6a-c841-3428-aeda-27a7c3fd78b8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 21.91, "targetHighPrice": 39.0, "targetLowPrice": 32.0, "targetMeanPrice": 35.25, "targetMedianPrice": 35.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 312390016, "totalCashPerShare": 6.613, "ebitda": -95954000, "totalDebt": 169000, "quickRatio": 14.132, "currentRatio": 14.392, "debtToEquity": 0.055, "returnOnAssets": -0.19549, "returnOnEquity": -0.28369, "freeCashflow": -31098876, "operatingCashflow": -72172000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]